Acasti Pharma Inc. (ACST) Stock Analysis
DELISTED 2024
What happened to Acasti Pharma Inc. (ACST) stock?
Acasti Pharma Inc. (ACST) no longer trades on public markets. It was delisted in November 2024. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- November 2024
- Last recorded price (historical):
- $3.37 (last quote on record before the November 2024 delisting; historical, not a current quote)
Market cap $34.2M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Acasti Pharma Inc. (ACST). Acasti Pharma Inc. is a biopharmaceutical company developing pharmaceutical products for cardiovascular diseases, headquartered in Laval, Canada. The company is actively evaluating strategic partnerships for the clinical development of its primary asset, CaPre.
Last analyzed: Jun 15, 2026Acasti Pharma Inc. (ACST) Healthcare & Pipeline Overview
More about this archive record
Can I still buy ACST shares?
No. ACST stopped trading on public markets in November 2024, so the shares are not available through a broker. Anything you see quoted for ACST elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before ACST stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Acasti Pharma Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.